JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Randomized-Control Screening Trials to Lower Gall Bladder Cancer Mortality in High Risk Populations
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Randomized-Control Screening Trials to Lower Gall Bladder Cancer Mortality in High Risk Populations
Krishnatreya, Manigreeva; Kataki, Amal Chandra;
  PDF(new window)
 Abstract
Gall bladder cancer is generally fatal. The high morbidity and mortality due to gall bladder cancer exerts a significant impact on efforts towards cancer control in high risk populations of the World and a rationale program for control of gall bladder cancer mortality has remained as an unmet need in these populations. Currently there are no effective strategies for controlling gall bladder cancer mortality. This mini review is to highlight the need and feasibility for secondary prevention of gall bladder cancer by screening in high risk populations. A way forward is to assess the role of secondary prevention of gall bladder cancers by conducting randomized-controlled screening trials in high risk populations.
 Keywords
Gall bladder cancer;mortality;screening trial;high risk population;
 Language
English
 Cited by
 References
1.
Andren-Sanberg A (2012). Diagnosis and management of gallbladder polyps. N Am J Med Sci, 4, 203-11 crossref(new window)

2.
Cha BH, Bae JM (2014). Comparison of clinical outcomes of incidental and non-incidental gallbladder cancers: a singlecenter cross- sectional study. Asian Pac J Cancer Prev, 15, 1281-3. crossref(new window)

3.
Duffy A, Capanu M, Abou-Alfa GK, et al (2008). Gallbladder cancer (GBC): 10-year experience at memorial sloankettering cancer centre (MSKCC). J Surg Oncol, 98,485-9. crossref(new window)

4.
Dutta U (2012). Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol, 27, 642-53 crossref(new window)

5.
Dwivedi S, Agrawal S, Singh S, et al (2015). Association of cytochrome-17 (mspa1) gene polymorphism with risk of gall bladder stones and cancer in North India. Asian Pac J Cancer Prev, 16, 5557-63. crossref(new window)

6.
Emmett CD, Barrett P, Gilliam AD, et al (2015). Routine versus selective histological examination after cholecystectomy to exclude incidental gallbladder carcinoma. Ann R Coll Surg Engl, 97, 526-9. crossref(new window)

7.
Furlan A, Ferris JV, Hosseinzadeh K, et al (2008). Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol, 191, 1440-7. crossref(new window)

8.
Hundal R, Shaffer EA (2014). Gallbladder cancer: epidemiology and outcome. Clin Epidemiol, 6, 99-109.

9.
Inui K, Yoshino J, Miyoshi H (2011). Diagnosis of gallbladder tumors. Intern Med, 50, 1133-6. crossref(new window)

10.
Jayaraman S, Jarnagin WR (2010). Management of gallbladder cancer. Gastroenterol Clin North Am, 39, 331-42. crossref(new window)

11.
Juffs HG, Tannock IF (2002). Screening trials are even more difficult than we thought they were. J Natl Cancer Inst, 94, 156-7. crossref(new window)

12.
Lai CH, Lau WY (2008). Gallbladder cancer- a comprehensive review. Surgeon, 6, 101-10. crossref(new window)

13.
Lazcano-Ponce EC, Miquel JF, Munoz N, et al (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64. crossref(new window)

14.
Mishra K, Behari A, Kapoor VK, et al (2015). Platelet derived growth factor-b and human epidermal growth factor receptor-2 polymorphisms in gall bladder cancer. Asian Pac J Cancer Prev, 16, 5647-54. crossref(new window)

15.
Mohandas KM, Patil PS (2006). Cholecystectomy for asymptomatic gallstones can reduce gall bladder cancer mortality in northern Indian women. Indian J Gastroenterol, 25, 147-51.

16.
Puschel K, Sullivan S, Montero J, et al (2002). Cost-effectiveness analysis of a preventive program for gallbladder disease in Chile. Rev Med Chil, 130, 447-59

17.
Rammohan A, Cherukuri SD, Sathyanesan J, et al (2014). Incidental gall bladder cancers: are they truly incidental? World J Gastrointest Oncol, 6, 441-3 crossref(new window)

18.
Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602 crossref(new window)

19.
Randi G, Malvezzi M, Levi F, et al (2009). Epidemiology of biliary tract cancers: an update. Ann Oncol, 20, 146-59

20.
Reid KM, Ramos-De la Medina A, Donohue JH (2007). Diagnosis and surgical management of gallbladder cancer: a r eview. J Gastrointest Surg, 11, 671-81. crossref(new window)

21.
Rodriguez-Fernandez A, Gqmez-Rio M, Medina-Benitez A, et al (2006). Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol, 93, 650-64 crossref(new window)

22.
Waghmare RS, Kamat RN (2014). Incidental gall bladder carcinoma in patients undergoing cholecystectomy: a report of 7 cases. J Assoc Physicians India, 62, 793-6.

23.
Wilson JMG, Jungner G (1968). Principles and practice of screening for disease. World Health Organization Public Health Papers, 34.

24.
Wistuba II, Gazdar AF (2004). Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer, 4, 695-706. crossref(new window)